Breaking News Instant updates and real-time market news.

HOG

Harley-Davidson

$37.98

-0.94 (-2.42%)

, TSEM

TowerJazz

$17.81

0.08 (0.45%)

10:12
04/24/19
04/24
10:12
04/24/19
10:12

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Harley-Davidson (HOG) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying he views Harley as the "worst positioned" within his Powersports coverage given its concentration in a "secularly declining" motorcycle market. 2. TowerJazz (TSEM) downgraded to Neutral from Outperform at Credit Suisse with analyst Quang Tung Le saying to reflect ongoing weakness at the company's "key" radio frequency and power customers along with revised three- year deal extension with Panasonic, the analyst reduced his sales estimates. 3. Marriott (MAR) downgraded to In Line from Outperform at Evercore ISI with analyst Rich Hightower saying approaching Q1 earnings season, the analyst finds himself "incrementally negative" on hotel stocks overall - and even more so with respect to the C-Corps than the REITs - given the sector's substantial recent outperformance against the relevant benchmarks, coupled with no obvious shift in fundamentals over the last 60-90 days. 4. Kraft Heinz (KHC) downgraded to Underweight from Neutral at Piper Jaffray with analyst Michael Lavery saying expectations for the company's 2020 earnings are likely too high as it plans divestitures of underperforming businesses, which could be 20c-30c dilutive on a per share basis. 5. Hyatt (H) and Hilton (HLT) downgraded to Market Perform from Outperform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

HOG

Harley-Davidson

$37.98

-0.94 (-2.42%)

TSEM

TowerJazz

$17.81

0.08 (0.45%)

MAR

Marriott

$135.45

-0.83 (-0.61%)

KHC

Kraft Heinz

$32.56

-0.53 (-1.60%)

H

Hyatt

$76.17

-0.35 (-0.46%)

HLT

Hilton

$87.57

-0.33 (-0.38%)

  • 01

    May

  • 02

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 15

    May

  • 15

    May

  • 28

    May

  • 29

    May

HOG Harley-Davidson
$37.98

-0.94 (-2.42%)

04/22/19
UBSW
04/22/19
NO CHANGE
Target $39
UBSW
Neutral
Harley-Davidson March retail sales seen down, says UBS
UBS analyst Robin Farley keeps her Neutral rating and $39 price target on Harley-Davidson saying its sales in March were likely down single digits, which brings the sales for Q1 to "down mid-single digits", even though the industry has "fared better". The analyst warns that the company's FY19 shipment guidance is at risk, anticipating a decline of 6% vs. the company's outlook of down 3%-5%.
04/24/19
GSCO
04/24/19
DOWNGRADE
Target $34
GSCO
Sell
Goldman downgrades 'worst positioned' Harley-Davidson to Sell from Neutral
Goldman Sachs analyst David Tamberrino downgraded Harley-Davidson (HOG) to Sell from Neutral and lowered his price target for the shares to $34 from $37. The stock closed yesterday down 78c to $38.92. The analyst views Harley as the "worst positioned" within his Powersports coverage given its concentration in a "secularly declining" motorcycle market. The company needs to grow its customer-base through rider academies as well as incremental marketing spend, Tamberrino tells investors in a research note. Further, Harley-Davidson's new product introductions into more crowded markets will likely lower its margins. While Harley's move into smaller bikes and electrification has longer-term benefits, the strategy could hurt profitability given the requirements for incremental spend, says the analyst. Lastly, Tamberrino sees risk to Harley-Davidson Financial Services as interest rates rise. The analyst this morning also initiated coverage of Polaris Industries (PII) with a Buy rating and BRP Inc. (DOOO) with a Neutral rating.
04/24/19
GSCO
04/24/19
DOWNGRADE
Target $34
GSCO
Sell
Harley-Davidson downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst David Tamberrino downgraded Harley-Davidson to Sell from Neutral and lowered his price target for the shares to $34 from $37.
04/08/19
WELS
04/08/19
DOWNGRADE
Target $41
WELS
Market Perform
Harley-Davidson risk/reward less attractive at current levels, says Wells Fargo
Wells Fargo analyst Timothy Conder downgraded Harley-Davidson to Market Perform from Outperform but raised his price target to $41 from $40, saying he believes risk/reward is now less attractive at current levels amid continued heavyweight motorcycle market weakness, tariff uncertainty and a "long" path to stabilization. Large heavyweight motorcycles, regardless of brand, remain challenged with ongoing new/used pricing and supply dynamics and a structural shift towards mid-size and smaller units, Conder says, adding that he believes Harley-Davidson's plans for mid-sized and small bikes, growing ridership and bringing in younger demographics to the brand and international expansion, collectively should provide a meaningful growth opportunity over time.
TSEM TowerJazz
$17.81

0.08 (0.45%)

10/30/18
LOOP
10/30/18
NO CHANGE
Target $28
LOOP
Buy
TowerJazz price target lowered to $28 from $36 at Loop Capital
Loop Capital analyst Cody Acree lowered his price target on TowerJazz to $28 after its Q3 results, also reducing his FY19 EPS view to $1.85 from $2.35. The analyst kept his Buy rating urged long-term investors to accumulate stock, stating that the current sell-off is significantly overdone. Acree adds that he is "encouraged" by the company's SiGe ramp, which "even in a softer chip environment is seeing its added capacity at full utilization".
10/30/18
CHLM
10/30/18
NO CHANGE
Target $21
CHLM
Buy
TowerJazz price target lowered to $21 from $29 at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for TowerJazz to $21 from $29 given Q3 results below consensus and continued trend of missed guidance. The analyst sees near-term macro uncertainty but believes long-term risk/reward is compelling. Shannon reiterates a Buy rating on the shares.
04/24/19
FBCO
04/24/19
DOWNGRADE
Target $19
FBCO
Neutral
Credit Suisse downgrades TowerJazz to Neutral on key customer weakness
Credit Suisse analyst Quang Tung Le downgraded TowerJazz to Neutral from Outperform while raising his price target for the shares to $19 from $18.10. To reflect ongoing weakness at the company's "key" radio frequency and power customers along with revised three- year deal extension with Panasonic, the analyst reduced his sales estimates. Further, Le remains skeptical about the extent of a gross margin recovery at TowerJazz from the lows in the first half of 2019. This may limit upside potential in the stock, Le tells investors in a research note. He also believes the company's 2020 sales may still be below 2018 levels.
04/24/19
FBCO
04/24/19
DOWNGRADE
FBCO
Neutral
TowerJazz downgraded to Neutral from Outperform at Credit Suisse
MAR Marriott
$135.45

-0.83 (-0.61%)

04/24/19
WELS
04/24/19
NO CHANGE
Target $141
WELS
Market Perform
Marriott price target raised to $141 from $123 at Wells Fargo
Wells Fargo analyst Jeffrey Donnelly raised his price target for Marriott (MAR) to $141 from $123 as concerns related to the breach and Starwood integration are fading and he expects the shares can revert to a 5%-10% premium to historical to averages or 15.5-times. In the near-term, the analyst suspects Marriott may have more incremental upside than Hilton (HLT) and Hyatt (H), but an insufficient amount to warrant his strongest rating. He reiterates a Market Perform rating on Marriott's shares.
04/24/19
EVER
04/24/19
DOWNGRADE
EVER
In Line
Marriott downgraded to In Line from Outperform at Evercore ISI
04/24/19
04/24/19
DOWNGRADE

In Line
Marriott downgraded to In Line on valuation at Evercore ISI
As previously reported, Evercore ISI analyst Rich Hightower downgraded Marriott to In Line from Outperform primarily on valuation. Approaching Q1 earnings season, the analyst finds himself "incrementally negative" on hotel stocks overall - and even more so with respect to the C-Corps than the REITs - given the sector's substantial recent outperformance against the relevant benchmarks, coupled with no obvious shift in fundamentals over the last 60-90 days.
03/05/19
LEHM
03/05/19
NO CHANGE
Target $135
LEHM
Overweight
Marriott price target raised to $135 from $128 at Barclays
Barclays analyst Anthony Powell raised his price target for Marriott International to $135 on a valuation roll forward to 2020 estimates. Marriott's Q4 results and forward guidance suggest that the "various idiosyncratic and temporary challenges" that were headwinds in 2018 should be less of an issue this year, Powell tells investors in a research note titled "A Cleaner Year of Growth Ahead." The analyst, however, keeps an Equal Weight rating on the shares.
KHC Kraft Heinz
$32.56

-0.53 (-1.60%)

03/18/19
STFL
03/18/19
NO CHANGE
Target $35
STFL
Hold
Kraft Heinz delay a setback, but shouldn't impact debt covenants, says Stifel
After Kraft Heinz reported late on Friday that it could not meet the deadline to file its 10-K with the SEC, Stifel analyst Christopher Growe called the news "another setback to the company in a string of disappointments of late," but added that he does not believe this means the SEC investigation has widened or that the filing impacts any of the company's debt covenants. He does not, however, think the company can pursue an asset sale now until the 10-K is filed. Growe, who expects the shares to trade down on this news given that investors currently have "a very skeptical tone" in relation to Kraft Heinz, keeps a Hold rating and $35 price target on the stock.
03/29/19
WOLF
03/29/19
DOWNGRADE
WOLF
Underperform
Kraft Heinz downgraded to Underperform from Peer Perform at Wolfe Research
03/04/19
03/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Foot Locker (FL) upgraded to Buy from Hold at Pivotal Research with analyst Mitch Kummetz saying the company on Friday reported much better than expected Q4 results, and its fiscal 2019 same-store-sales and earnings growth outlook was also well above consensus. 2. Hasbro (HAS) upgraded to Market Perform from Underperform at BMO Capital with analyst Gerrick Johnson saying the stock's multiple will expand as "major theatrical events" approach later in the year. 3. Hertz (HTZ) upgraded to Buy from Neutral at Northcoast. 4. Extended Stay America (STAY) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Grambling citing the company's Q4 earnings report. 5. Kraft Heinz (KHC) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying he believes FY19 estimates now look achievable following their recent correction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/24/19
PIPR
04/24/19
DOWNGRADE
Target $31
PIPR
Underweight
Kraft Heinz downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst Michael Lavery downgraded Kraft Heinz to Underweight from Neutral and lowered his price target for the shares to $31 from $35. Expectations for the company's 2020 earnings are likely too high as it plans divestitures of underperforming businesses, which could be 20c-30c dilutive on a per share basis, Lavery tells investors in a research note. He believes a new CEO is the right move, but also that incremental brand spending is needed to rejuvenate Kraft Heinz's "dusty brands," which he thinks could weigh on earnings by another 15c-20c per share.
H Hyatt
$76.17

-0.35 (-0.46%)

01/08/19
01/08/19
DOWNGRADE

Market Perform
Hyatt downgraded to Market Perform on more cautious macro view at Raymond James
As previously reported, Raymond James downgraded Hyatt to Market Perform from Outperform. Analyst William Crow said he is taking a more defensive stance towards the broader markets and expectations for a slowing US and global economic backdrop. The analyst said Hyatt's transition has come in "fits and starts," and expects asset sales to slow significantly in 2019.
04/24/19
WELS
04/24/19
DOWNGRADE
Target $80
WELS
Market Perform
Hyatt downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jeffrey Donnelly downgraded Hyatt to Market Perform from Outperform, with $80 price target, as he feels valuation is maximized and fails to see a catalyst to support incremental appreciation. The analyst expects Hyatt will continue to trade in line with REIT and brand peers due to its mix of owned real estate and fee businesses.
01/08/19
RAJA
01/08/19
DOWNGRADE
RAJA
Market Perform
Hyatt downgraded to Market Perform from Outperform at Raymond James
HLT Hilton
$87.57

-0.33 (-0.38%)

03/14/19
ARGS
03/14/19
UPGRADE
Target $96
ARGS
Buy
Hilton upgraded to Buy from Hold at Argus
Argus analyst John Staszak upgraded Hilton to Buy with a price target of $96, saying the company should see above-peer-average earnings growth over time thanks to its "asset-light business model, in which it franchises rather than owns hotels". The analyst is also positive on the company's "industry-leading loyalty program with approximately 85 million members" as well as its potential to increase market share with about 20% of its rooms "currently under development worldwide". Staszak further cites Hilton earnings topping forecasts in 8 of the past 9 quarters, raising his FY19 and FY20 EPS outlook by 10c to $3.90 and $4.40 respectively.
04/24/19
WELS
04/24/19
DOWNGRADE
Target $90
WELS
Market Perform
Hilton downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jeffrey Donnelly downgraded Hilton to Market Perform from Outperform as he feels valuation is maximized and fails to see a catalyst to support incremental appreciation. The analyst also raised his price target on the shares to $90 from $88.
03/14/19
03/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Mills (GIS) upgraded to Buy from Hold at Deutsche Bank with analyst Rob Dickerson saying although the stock is up 20% year-to-date, pressure still exists in the company's snack bar and soup categories, and divestment dilution risk looms. 2. Snap (SNAP) upgraded to Buy from Neutral at BTIG with analyst Richard Greenfield citing the "surge in spending in North America on Snapchat from advertisers," who are increasingly focused on its "compelling" return on investment. 3. Hilton (HLT) upgraded to Buy from Hold at Argus with analyst John Staszak saying the company should see above-peer-average earnings growth over time thanks to its "asset-light business model, in which it franchises rather than owns hotels." 4. Forum Energy (FET) upgraded to Buy from Neutral at Citi with analyst Scott Gruber saying the company has made free cash flow a priority and believes it can generate $100M annually. 5. Petrobras (PBR) upgraded to Buy from Hold at HSBC. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

T

AT&T

$32.36

0.06 (0.19%)

, CMCSA

Comcast

$42.31

0.62 (1.49%)

17:58
06/16/19
06/16
17:58
06/16/19
17:58
On The Fly
Box Office Battle: 'Men in Black: International' wins weekend with just $28.5M »

Sony’s (SNE) "Men in…

T

AT&T

$32.36

0.06 (0.19%)

CMCSA

Comcast

$42.31

0.62 (1.49%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.42

1.735 (3.49%)

LGF.A

Lionsgate

$12.22

-0.85 (-6.50%)

DIS

Disney

$141.64

-0.09 (-0.06%)

VIAB

Viacom

$29.38

-0.28 (-0.94%)

VIA

Viacom

$34.61

0.14 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Jul

  • 25

    Jul

  • 08

    Aug

  • 08

    Aug

GS

Goldman Sachs

$191.71

0.24 (0.13%)

17:43
06/16/19
06/16
17:43
06/16/19
17:43
Periodicals
Goldman Sachs combining private-investing units, WSJ reports »

Goldman Sachs is pulling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

DB

Deutsche Bank

$6.79

-0.07 (-1.02%)

17:38
06/16/19
06/16
17:38
06/16/19
17:38
Periodicals
Deutsche Bank to set up EUR50B bad bank, Financial Times reports »

Deutsche Bank is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$87.10

(0.00%)

16:35
06/16/19
06/16
16:35
06/16/19
16:35
Periodicals
Tires blow on United jet during Newark airport landing, Reuters reports »

Tires on a United…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$87.83

-0.48 (-0.54%)

16:33
06/16/19
06/16
16:33
06/16/19
16:33
Periodicals
Target registers back online after outage blamed on tech issue, Reuters says »

Target said its payment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$46.18

-0.54 (-1.16%)

16:30
06/16/19
06/16
16:30
06/16/19
16:30
Hot Stocks
Intel announces program for Israeli startups targeting tech inflections »

Intel announced a program…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:27
06/16/19
06/16
16:27
06/16/19
16:27
Periodicals
Boeing says will take time to rebuild customer confidence, Reuters reports »

The head of Boeing said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

GS

Goldman Sachs

$191.71

0.24 (0.13%)

16:19
06/16/19
06/16
16:19
06/16/19
16:19
Periodicals
Goldman Sachs skeptical of 'insurance' rate cuts from Fed, Reuters says »

Goldman Sachs economists…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:16
06/16/19
06/16
16:16
06/16/19
16:16
Periodicals
Trials nearing for Boeing 737 Max fix, WSJ reports »

The Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

ESLT

Elbit Systems

$154.55

0.55 (0.36%)

13:41
06/16/19
06/16
13:41
06/16/19
13:41
Hot Stocks
Elbit Systems awarded $50M contract »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$176.09

-0.74 (-0.42%)

13:40
06/16/19
06/16
13:40
06/16/19
13:40
Hot Stocks
Amgen announces BLINCYTO five-year overall survival data »

Amgen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

SILK

Silk Road Medical

$44.80

-0.95 (-2.08%)

13:35
06/16/19
06/16
13:35
06/16/19
13:35
Hot Stocks
Silk Road Medical announces final results for ROADSTER-2 study »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 26

    Aug

EDIT

Editas Medicine

$21.72

-0.78 (-3.47%)

13:30
06/16/19
06/16
13:30
06/16/19
13:30
Hot Stocks
Editas presents pre-clinical data in Sickle Cell Disease, Beta-Thalassemia »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNSS

Sunesis

$0.90

-0.055 (-5.79%)

13:28
06/16/19
06/16
13:28
06/16/19
13:28
Hot Stocks
Sunesis announces preliminary data from Phase 1b/2 trial of Vecabrutinib »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

APLS

Apellis

$21.22

-0.14 (-0.66%)

13:23
06/16/19
06/16
13:23
06/16/19
13:23
Hot Stocks
Apellis presents data from ongoing Phase 2 PLAUDIT study of APL-2 »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

FTSV

Forty Seven

$10.55

-0.02 (-0.19%)

13:16
06/16/19
06/16
13:16
06/16/19
13:16
Hot Stocks
Forty Seven announces data from Phase 1b/2 trial of 5F9 in combo with Rituximab »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

13:06
06/16/19
06/16
13:06
06/16/19
13:06
Hot Stocks
AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

STRO

Sutro Biopharma

$11.17

-0.34 (-2.95%)

13:02
06/16/19
06/16
13:02
06/16/19
13:02
Hot Stocks
Sutro Biopharma announces interim Phase 1 safety data for STRO-001 »

Sutro Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$90.65

-0.35 (-0.38%)

12:59
06/16/19
06/16
12:59
06/16/19
12:59
Hot Stocks
Blueprint Medicines presents updated EXPLORER trial data for Avapritinib »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

INCY

Incyte

$77.76

1.385 (1.81%)

12:52
06/16/19
06/16
12:52
06/16/19
12:52
Hot Stocks
Incyte announced results from Phase 2 study of Ruxolitinib cream in vitiligo »

Incyte announces 24-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/16/19
06/16
04:55
06/16/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

, GRUB

GrubHub

$70.15

-2.76 (-3.79%)

13:28
06/15/19
06/15
13:28
06/15/19
13:28
Periodicals
Amazon exit gives GrubHub stock boost, Barron's says »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

, CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

13:20
06/15/19
06/15
13:20
06/15/19
13:20
Periodicals
McKesson, Cardinal Health looking like bargains, Barron's says »

Investors have halved the…

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

RTN

Raytheon

$177.38

0.195 (0.11%)

, UTX

United Technologies

$125.30

0.45 (0.36%)

13:09
06/15/19
06/15
13:09
06/15/19
13:09
Periodicals
United Technologies, Raytheon stocks looking cheap, Barron's says »

Shares of United…

RTN

Raytheon

$177.38

0.195 (0.11%)

UTX

United Technologies

$125.30

0.45 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

, AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

13:04
06/15/19
06/15
13:04
06/15/19
13:04
Periodicals
Food fight extending well beyond restaurant delivery, Barron's says »

Amazon (AMZN) is quitting…

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.